Results for 'IO'
Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
City of Hope, Monty Pal, John Carpten, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…
Mar 23rd • 56 mins listen
Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
City of Hope, Monty Pal, Anna Wu, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…
Mar 9th • 42 mins listen
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Kirk Shepard
Humans Beyond the Algorithm: Hiring for Oncology’s Future
Stacy Benefiel, AI, Talent, Workforce Innovation, Human Resources, HR
In episode 4 of Oncology Voice Network Podcast, Host Dr. Kirk Shepard welcomes Stacey Benefiel, PharmD, Head of Global Clinical and Medical Affairs at Canopy, for a candid exploration of what it really takes to build the future oncology workforce.
Mar 3rd • 23 mins listen
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Monty Pal
Advancing Cancer Survivorship and Cardio-Oncology
City of Hope, Monty Pal, Saro Armenian, pediatric, cardio-oncology, CHIP clinic
Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.
Feb 24th • 39 mins listen
Monty Pal
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
City of Hope, Monty Pal, Edward Kim, integrative oncology, national clinical trial, patient access
Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.
Mar 21st • 33 mins listen
Monty Pal
Humanizing Cancer Treatment Through Whole-Person Care
City of Hope, Monty Pal, Betty Ferrell, palliative care, quality of life, pain management, bone marrow transplantation, Ethiopia
Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.
Apr 21st • 47 mins listen
Monty Pal
Building the First AI Agent for Cancer Research
City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic
Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.
May 5th • 49 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Monty Pal
At the Crossroads of Cancer and Metabolism
City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
Jul 7th • 37 mins listen
Monty Pal
How Team Science is Driving Lung Cancer Breakthroughs
City of Hope, Monty Pal, Loretta Erhunmwunsee, lung cancer, thoracic surgeon, air pollution, diversity
Dr. Loretta Erhunmwunsee explores her latest groundbreaking research investigating the impact of air pollution on lung cancer and shares how team science is critical to advancing cancer care for all.
Aug 19th • 32 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
Rebecca Previs, Suzanne Garner, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care
Labcorp, Rebecca Previs, Mark Sausen, immunotherapy, mesothelioma, checkpoint blockade, ctDNA, imaging
Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Nov 3rd • 15 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
Labcorp, Rebecca Previs, Kyle Strickland, Erin Newburn, biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
Rebecca Previs, Dawn McHugh, Labcorp, precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen